American Herbal Products Association (AHPA) > About Us > Committees > Cannabis Committee

About

The American Herbal Products Association (AHPA) is the only national trade organization that has embraced the cannabis industry as part of the herbal products marketplace, with all the advantages that experience provides. For nearly 40 years, AHPA's mission has been to promote the responsible commerce of herbal products to ensure that consumers have informed access to a wide variety of herbal goods. Since 2010, we have been actively involved in the regulatory, legislative, and technical aspects of moving cannabis into the legal marketplace.

When an herb experiences explosive growth, it attracts players with both short and long term interest. Working to institute a level playing field can help ensure the cannabis market has a long future as a significant segment of the herb industry. For those companies intending to build long term, sustainable businesses, involvement in AHPA demonstrates that the responsible core of the industry is viewed by regulatory agencies and legislators as just that.

AHPA and Cannabis: Quick Facts

  • The indispensable support we’ve provided to companies trading in herbs for decades is vital to the cannabis market.
  • AHPA offers unmatched understanding of the FDA and its food and dietary supplement regulations, particularly pertaining to the hemp and CBD marketplace.
  • The collective resources available to AHPA members includes significant regulatory and legal compliance expertise to help you protect and grow your company.
  • AHPA’s active advocacy in the regulatory, legislative, education, and technical aspects of moving cannabis into the legal marketplace spans a decade.
  • For nearly 40 years, AHPA has been the only trade organization working exclusively with “herbs of commerce,” helping members bring products to market in a highly regulated environment.
  • The cannabis industry’s most influential companies and legal partners are AHPA members.

Committee Purpose

Address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species.

Committee Members

AHPA members include the most influential companies and legal partners working to ensure a stable, long-term cannabis industry. Whether you’re growing and harvesting, processing, manufacturing, testing or marketing, our expertise provides crucial support from seed to sale. If your goal is to grow a sustainable business, join our community to help shape the future of the cannabis marketplace.

Committee Chair

Asa Waldstein (Supplement Advisory Group)

Join

AHPA Members

Membership is open to all AHPA members. Contact Jane Wilson to join the committee today! Learn more about the committee here >>

Not an AHPA Member yet?

Learn more about the many benefits of AHPA membership and contact Amber Bennett to join today!

Resources

Email Alerts

Subscribe to receive Cannabis Alerts via email.

Guidance

Recommendations for Regulators


Meeting Minutes

November 9, 2020 Meeting Minutes

Meeting of the Cannabis Committee

October 18, 2019 Meeting Minutes

Meeting of the Cannabis Committee

AHPA Members log in to download the meeting minutes.

March 7, 2019 Meeting Minutes

Meeting of the Cannabis Committee

AHPA Members log in to download the meeting minutes.
RSS

Committee-Related News

AHPA President Michael McGuffin delivers keynote at 26th Annual Hemp Industries Association Conference (HIACON)

AHPA President Michael McGuffin delivers keynote at 26th Annual Hemp Industries Association Conference (HIACON)

McGuffin discusses opportunities and challenges for those marketing hemp-CBD as a dietary supplement

AHPA President Michael McGuffin discussed opportunities and challenges for companies marketing hemp and cannabidiol (CBD) in products labeled as dietary supplements at the 26th Annual Hemp Industries Association Conference (HIACON) held in Charlotte, NC this week.

AHPA joins dietary supplement industry to urge swift congressional action on CBD

Congress urged to pass legislation to clarify that CBD derived from hemp is a lawful dietary ingredient

This week, the four leading trade associations representing the U.S. dietary supplement industry joined forces to urge Congress to take action to ensure consumer safety and provide legal clarity in the cannabidiol (CBD) product marketplace. In a letter, the American Herbal Products Association (AHPA), Consumer Healthcare Products Association (CHPA), Council for Responsible Nutrition (CRN), and United Natural Products Alliance (UNPA) called on Congress “to pass legislation to clarify that CBD derived from the hemp plant is a lawful dietary ingredient if the dietary supplement containing the CBD meets established product safety and quality criteria.”

Guidance: Federal Labeling Requirements for Herbal Dietary Supplements

Updated to reflect changes from May 2016 Final Rule revising FDA’s nutrition labeling regulations

AHPA has revised it's labeling guidance for herbal dietary supplements to cover updated nutrition labeling requirements for foods and dietary supplements that are scheduled to take effect January 1, 2020 for manufacturers with $10 million or more in annual sales and January 1, 2021 for smaller manufacturers.
CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

USDA and FDA officials share key information for companies selling hemp-CBD in dietary supplements

Colorado Governor Jared Polis rallied more than 200 hemp farmers, manufacturers, producers, retailers, and industry professionals during his keynote address to the American Herbal Products Association (AHPA) Hemp-CBD (cannabidiol) Supplement Congress held earlier this month.

CA Prop 65 Guidance for Hemp Products

Regulatory and liability implications of Proposition 65 for hemp and hemp-derived products

AHPA has published Guidance on California Proposition 65 and Hemp Products to educate the hemp industry about the regulatory and liability implications of Proposition 65 for hemp and hemp-derived products, including cannabidiol (CBD), sold in the State of California.

AHPA urges FDA to protect consumers by quickly clarifying hemp-CBD regulations

Existing supplement and food regulations are sufficiently robust for hemp-derived ingredients

The American Herbal Products Association (AHPA) urged the Food and Drug Administration (FDA) last week to protect consumers by quickly taking specific actions to clarify the regulatory status of hemp and hemp-derived ingredients used in dietary supplements and foods that contain cannabidiol (CBD).

Revised Hemp-CBD Status Report

How hemp and CBD companies are impacted by recent actions by the USDA and FDA

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

Sen. Wyden's request aligns with AHPA's hemp-CBD advocacy

Sen. Ron Wyden (D-OR), a co-author of the hemp provisions included in the 2018 Farm Bill, sent letters to Food and Drug Administration (FDA) Commissioner Ned Sharpless and Health & Human Services (HHS) Secretary Alex Azar urging the agencies to promptly create a regulatory pathway to use cannabidiol (CBD) as a food additive and as a dietary ingredient in dietary supplements.
More than 30 AHPA members and staff participate in the 2019 Day on the Hill

More than 30 AHPA members and staff participate in the 2019 Day on the Hill

AHPA partners with CRN, CHPA and UNPA to produce this unique advocacy opportunity

More than 30 AHPA member company executives—including company presidents, regulatory experts, and government relations executives—with a vested interest in legislative activity in Congress—flew in from across the nation, for a full day of networking and discussions with members of Congress and their staff. 

AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

McGuffin recommends FDA issue interim final rule with an accelerated effective date

American Herbal Products Association (AHPA) President Michael McGuffin urged the Food and Drug Administration (FDA) to use existing authority to quickly create a lawful pathway -- including considering issuing a interim final rule -- for marketing of cannabidiol (CBD)-containing supplements and foods at a public meeting held by FDA in Silver Spring, MD.
RSS
1234

2020 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.